Press Release

John Sweeney to focus on technology development and partnerships

BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 12, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division.

“John is uniquely qualified to continue the transformation of our Life Science business,” said Jonathan DiVincenzo, President of Millipore’s Bioscience Division. “His success in the areas of strategy and business development will be invaluable in our efforts to bring innovative new products and solutions to our customers working in protein research and cell biology.”

Sweeney joined Millipore in 2003 as Director of Strategy and Corporate Development. In that role, he was responsible for long range strategic planning and served as the lead on execution of key M&A and partnership transactions, including Millipore’s $1.4 billion acquisition of Serologicals.

“Millipore has a tremendous opportunity to help our customers advance significant scientific research that could ultimately cure some of the world’s most challenging human health issues,” said Sweeney. “Our goal is to continue to create true solutions to customer problems through the introduction of cutting-edge devices, instruments and reagents that meet the rapidly changing needs of scientists"

In his most recent role, Sweeney transformed Millipore's web presence, generating double-digit growth. He also built the Bioscience Business Development team which has resulted in several innovation partnerships and the acquisitions of Guava and Epitome.

“Creating new partnerships and developing new technologies are both crucial to Millipore’s continued growth.” added Sweeney. “I look forward to furthering that growth in our life science business.”

Sweeney is a graduate of the University of Pennsylvania and earned a Master of Business Administration degree from the Tuck School of Business at Dartmouth.

About Millipore

Millipore (NYSE: MIL) is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees in 30 countries worldwide.

Advancing Life Science Together™

Research. Development. Production.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6028499&lang=en

Source: Millipore Corporation

For Media
Karen Marinella Hall, 978-715-1567
Director of Corporate Communications
karen_hall@millipore.com
or
For Investors
Millipore Corporation
Joshua Young, 978-715-1527
Director, Investor Relations
joshua_young@millipore.com